Evidence map›Paper›PMID 31509716›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Changes in brain kynurenine levels

Pablo Giménez-Gómez, Mercedes Pérez-Hernández, Esther O'Shea, Javier R Caso, David Martín-Hernandez, Luis Alou Cervera, María Luisa Gómez-Lus Centelles, María Dolores Gutiérrez-Lopez, Maria Isabel Colado

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Cyclic Nucleotide Phosphodiesterases in Alcohol Use Disorders: Involving Gut Microbiota.The international journal of neuropsychopharmacology · 2023
    Article
  6. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Pablo Giménez-Gómez *Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Mercedes Pérez-Hernández *Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Esther O'SheaDepartamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Javier R CasoDepartamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
David Martín-HernandezDepartamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Luis Alou CerveraÁrea de Microbiología, Departamento de Medicina, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
María Luisa Gómez-Lus CentellesÁrea de Microbiología, Departamento de Medicina, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
María Dolores Gutiérrez-LopezDepartamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Maria Isabel ColadoDepartamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Instituto de Salud Carlos III · ESUniversidad Complutense de Madrid · ESCentro de Investigación Biomédica en Red de Salud Mental · ESResearch Institute Hospital 12 de Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory processes have been shown to modify tryptophan (Trp) metabolism. Gut microbiota appears to play a significant role in the induction of peripheral and central inflammation. Ethanol (EtOH) exposure alters gut permeability, but its effects on Trp metabolism and the involvement of gut microbiota have not been studied. We analyzed several parameters of gut-barrier and of peripheral and central Trp metabolism following 2 different EtOH consumption patterns in mice, the binge model, drinking in the dark (DID), and the chronic intermittent (CI) consumption paradigm. Antibiotic treatment was used to evaluate gut microbiota involvement in the CI model. Mice exposed to CI EtOH intake, but not DID, show bacterial translocation and increased plasma LPS immediately after EtOH removal. Gut-barrier permeability to FITC-dextran is increased by CI, and, furthermore, intestinal epithelial tight-junction (TJ) disruption is observed (decreased expression of zonula occludens 1 and occludin) associated with increased matrix metalloproteinase (MMP)-9 activity and iNOS expression. CI EtOH, but not DID, increases kynurenine (Kyn) levels in plasma and limbic forebrain. Intestinal bacterial decontamination prevents the LPS increase but not the permeability to FITC-dextran, TJ disruption, or the increase in MMP-9 activity and iNOS expression. Although plasma Kyn levels are not affected by antibiotic treatment, the elevation of Kyn in brain is prevented, pointing to an involvement of microbiota in CI EtOH-induced changes in brain Trp metabolism. Additionally, CI EtOH produces depressive-like symptoms of anhedonia, which are prevented by the antibiotic treatment thus pointing to an association between anhedonia and the increase in brain Kyn and to the involvement of gut microbiota.-Giménez-Gómez, P., Pérez-Hernández, M., O'Shea, E., Caso, J. R., Martín-Hernández, D., Cervera, L. A., Centelles. M. L. G.-L., Gutiérrez-Lopez, M. D., Colado, M. I. Changes in brain kynurenine levels

Indexed as

AnimalsBehavior, AnimalBrainEthanolGastrointestinal MicrobiomeKynurenineMaleMiceMice, Inbred C57BLEthanolKynurenineiNOSLPSMMPs

Identifiers

PMID31509716
PMCPMC6902706
OpenAlexW2973096894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.